SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-127353
Filing Date
2023-12-19
Accepted
2023-12-19 16:45:12
Documents
12
Period of Report
2023-12-05
Items
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333261d1_8k.htm   iXBRL 8-K 23300
  Complete submission text file 0001104659-23-127353.txt   194089

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA axla-20231205.xsd EX-101.SCH 3030
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE axla-20231205_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axla-20231205_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2333261d1_8k_htm.xml XML 3215
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 231498000
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)